Systemic Antifungal Drugs for Onychomycosis.
10.17966/KJMM.2016.21.4.105
- Author:
Hyojin KIM
1
;
So Hee PARK
;
Ki Hong KIM
Author Information
1. Department of Dermatology, College of Medicine, Inje University, Korea. pituitarygland@hanmail.net
- Publication Type:Review
- Keywords:
Fluconazole;
Itraconazole;
Onychomycosis;
Terbinafine
- MeSH:
Antifungal Agents;
Drug Interactions;
Fluconazole;
Itraconazole;
Onychomycosis*;
Recurrence
- From:Korean Journal of Medical Mycology
2016;21(4):105-110
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Onychomycosis is a common disease that requires appropriate management. Systemic antifungal agents are current standard for onychomycosis treatment. Considering high recurrence rate, selection of the systemic antifungal agent should be based primarily on the causative organism, the potential adverse effects and the risk of drug interactions. Herein, we reviewed systemic antifungal agent for onychomycosis.
